Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas
- PMID: 34367997
- PMCID: PMC8339963
- DOI: 10.3389/fonc.2021.712950
Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas
Abstract
Background: Significant racial disparities in pancreatic cancer incidence and mortality rates exist, with the highest rates in African Americans compared to Non-Hispanic Whites and Hispanic/Latinx populations. Computer-derived quantitative imaging or "radiomic" features may serve as non-invasive surrogates for underlying biological factors and heterogeneity that characterize pancreatic tumors from African Americans, yet studies are lacking in this area. The objective of this pilot study was to determine if the radiomic tumor profile extracted from pretreatment computed tomography (CT) images differs between African Americans, Non-Hispanic Whites, and Hispanic/Latinx with pancreatic cancer.
Methods: We evaluated a retrospective cohort of 71 pancreatic cancer cases (23 African American, 33 Non-Hispanic White, and 15 Hispanic/Latinx) who underwent pretreatment CT imaging at Moffitt Cancer Center and Research Institute. Whole lesion semi-automated segmentation was performed on each slice of the lesion on all pretreatment venous phase CT exams using Healthmyne Software (Healthmyne, Madison, WI, USA) to generate a volume of interest. To reduce feature dimensionality, 135 highly relevant non-texture and texture features were extracted from each segmented lesion and analyzed for each volume of interest.
Results: Thirty features were identified and significantly associated with race/ethnicity based on Kruskal-Wallis test. Ten of the radiomic features were highly associated with race/ethnicity independent of tumor grade, including sphericity, volumetric mean Hounsfield units (HU), minimum HU, coefficient of variation HU, four gray level texture features, and two wavelet texture features. A radiomic signature summarized by the first principal component partially differentiated African American from non-African American tumors (area underneath the curve = 0.80). Poorer survival among African Americans compared to Non-African Americans was observed for tumors with lower volumetric mean CT [HR: 3.90 (95% CI:1.19-12.78), p=0.024], lower GLCM Avg Column Mean [HR:4.75 (95% CI: 1.44,15.37), p=0.010], and higher GLCM Cluster Tendency [HR:3.36 (95% CI: 1.06-10.68), p=0.040], and associations persisted in volumetric mean CT and GLCM Avg Column after adjustment for key clinicopathologic factors.
Conclusions: This pilot study identified several textural radiomics features associated with poor overall survival among African Americans with PDAC, independent of other prognostic factors such as grade. Our findings suggest that CT radiomic features may serve as surrogates for underlying biological factors and add value in predicting clinical outcomes when integrated with other parameters in ongoing and future studies of cancer health disparities.
Keywords: blacks; cancer disparities; pancreatic cancer; quantitative imaging; radiomics.
Copyright © 2021 Permuth, Vyas, Li, Chen, Jeong and Choi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.World J Gastroenterol. 2020 Jun 28;26(24):3458-3471. doi: 10.3748/wjg.v26.i24.3458. World J Gastroenterol. 2020. PMID: 32655269 Free PMC article.
-
Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.J Appl Clin Med Phys. 2017 Nov;18(6):32-48. doi: 10.1002/acm2.12170. Epub 2017 Sep 11. J Appl Clin Med Phys. 2017. PMID: 28891217 Free PMC article.
-
Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.Eur Radiol. 2020 Jan;30(1):195-205. doi: 10.1007/s00330-019-06381-8. Epub 2019 Aug 7. Eur Radiol. 2020. PMID: 31392481 Free PMC article.
-
Computed tomography-based radiomics approach in pancreatic tumors characterization.Radiol Med. 2021 Aug 12. doi: 10.1007/s11547-021-01405-0. Online ahead of print. Radiol Med. 2021. PMID: 34386897 Review.
-
Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?Front Neurol. 2023 Jun 28;14:1215774. doi: 10.3389/fneur.2023.1215774. eCollection 2023. Front Neurol. 2023. PMID: 37448745 Free PMC article. Review.
Cited by
-
Mesothelin expression prediction in pancreatic cancer based on multimodal stochastic configuration networks.Med Biol Eng Comput. 2025 Apr;63(4):1117-1129. doi: 10.1007/s11517-024-03253-2. Epub 2024 Dec 6. Med Biol Eng Comput. 2025. PMID: 39641869
-
Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study.Cancers (Basel). 2023 Jun 28;15(13):3392. doi: 10.3390/cancers15133392. Cancers (Basel). 2023. PMID: 37444502 Free PMC article.
-
Pancreatic Ductal Adenocarcinoma (PDAC): A Review of Recent Advancements Enabled by Artificial Intelligence.Cancers (Basel). 2024 Jun 17;16(12):2240. doi: 10.3390/cancers16122240. Cancers (Basel). 2024. PMID: 38927945 Free PMC article. Review.
-
Role of Machine Learning in Precision Oncology: Applications in Gastrointestinal Cancers.Cancers (Basel). 2022 Dec 22;15(1):63. doi: 10.3390/cancers15010063. Cancers (Basel). 2022. PMID: 36612061 Free PMC article. Review.
-
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.J Natl Med Assoc. 2023 Apr;115(2):164-174. doi: 10.1016/j.jnma.2023.01.008. Epub 2023 Feb 17. J Natl Med Assoc. 2023. PMID: 36801148 Free PMC article. Review.
References
-
- Howlader N, Noone Am, Krapcho M, Miller D, Bishop K, Altekruse Sf, et al. . Seer Cancer Statistics Review, 1975-2013. Bethesda, Md: National Cancer Institute. Based on November 2015 Seer Data Submission, Posted to the Seer Web Site, April (2016).
LinkOut - more resources
Full Text Sources